Ciliary neurotrophic factor analogue aggravates CCl4-induced acute hepatic injury in rats

被引:2
作者
Cui, Ming-Xia [1 ,2 ]
Jiang, Jun-Feng [3 ]
Min, Guang-Ning [4 ]
Han, Wei [5 ]
Wu, Yong-Jie [1 ,2 ]
机构
[1] Lanzhou Univ, Sch Basic Med Sci, Inst Pharmacol, Lanzhou 730000, Peoples R China
[2] Key Lab Preclin Study New Drug Gansu Prov, Lanzhou 730000, Peoples R China
[3] Gansu Prov Canc Hosp, Lanzhou 730050, Peoples R China
[4] Lanzhou Univ, Hosp 1, Lanzhou 730000, Peoples R China
[5] Dingxi Dist Gansu Univ Chinese Med, Dingxi 743000, Peoples R China
基金
中国国家自然科学基金;
关键词
ciliary neurotrophic factor (CNTF); carbon tetrachloride (CCl4); fatty liver; liver injury; lipid peroxidation; CARBON-TETRACHLORIDE; LIVER-INJURY; FACTOR CNTF; DAMAGE;
D O I
10.1139/cjpp-2016-0564
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
Ciliary neurotrophic factor (CNTF) and CNTF analogs were reported to have hepatoprotective effect and ameliorate hepatic steatosis in db/db or high-fat-diet-fed mice. Because hepatic steatosis and injury are also commonly induced by hepatotoxin, the aim of the present study is to clarify whether CNTF could alleviate hepatic steatosis and injury induced by carbon tetrachloride (CCl4). Unexpectedly, when combined with CCl4, CNTF aggravated hepatic steatosis and liver injury. The mechanism is associated with effects of CNTF that inhibited lipoprotein secretion and drastically impaired the ability of lipoproteins to act as transport vehicles for lipids from the liver to the circulation. While injected after CCl4 cessation, CNTF could improve liver function. These data suggest that CNTF could be a potential hepatoprotective agent against CCl4-induced hepatic injury after the cessation of CCl4 exposure. However, it is forbidden to combine recombinant mutant of human CNTF treatment with CCl4.
引用
收藏
页码:620 / 623
页数:4
相关论文
共 18 条
[1]  
Boll M, 2001, Z NATURFORSCH C, V56, P283
[2]  
*CAN COUNC AN CAR, 1993, GUID CAR US EXP AN, V1
[3]   Vesicular (liposomal and nanoparticulated) delivery of curcumin: a comparative study on carbon tetrachloride-mediated oxidative hepatocellular damage in rat model [J].
Choudhury, Somsubhra Thakur ;
Das, Nirmalendu ;
Ghosh, Swarupa ;
Ghosh, Debasree ;
Chakraborty, Somsuta ;
Ali, Nahid .
INTERNATIONAL JOURNAL OF NANOMEDICINE, 2016, 11 :2179-2193
[4]   Therapeutic effects of a recombinant mutant of the human ciliary neurotrophic factor in a mouse model of metabolic syndrome [J].
Cui, Ming-Xia ;
Jiang, Jun-Feng ;
Zheng, Rong-Liang ;
Li, Rui-Lian ;
Wang, Lei ;
Li, Wen-Guang ;
Gao, Ming-Tang ;
Yang, Li-Ning ;
Dou, Jin-Yan ;
Wu, Yong-Jie .
PHARMAZIE, 2010, 65 (04) :279-283
[5]  
Finelli C, 2012, J GASTROINTEST LIVER, V21, P293
[6]   Forum - Mechanisms of hepatotoxicity [J].
Jaeschke, H ;
Gores, GJ ;
Cederbaum, AI ;
Hinson, JA ;
Pessayre, D ;
Lemasters, JJ .
TOXICOLOGICAL SCIENCES, 2002, 65 (02) :166-176
[7]   Ciliary neurotrophic factor activates leptin-like pathways and reduces body fat, without cachexia or rebound weight gain, even in leptin-resistant obesity [J].
Lambert, PD ;
Anderson, KD ;
Sleeman, MW ;
Wong, V ;
Tan, J ;
Hijarunguru, A ;
Corcoran, TL ;
Murray, JD ;
Thabet, KE ;
Yancopoulos, GD ;
Wiegand, SJ .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2001, 98 (08) :4652-4657
[8]  
Li R., 2016, OXIDATIVE MED CELLUL, V2016, DOI DOI 10.1155/2016/9203716.PMID:26881046
[9]   The novel mechanism of recombinant human ciliary neurotrophic factor on the anti-diabetes activity [J].
Liu, Qing-Shan ;
Gao, Mei ;
Zhu, Shen-Yin ;
Lie, Shao-Jing ;
Zhang, Li ;
Wang, Qiu-Juan ;
Du, Guan-Hua .
BASIC & CLINICAL PHARMACOLOGY & TOXICOLOGY, 2007, 101 (02) :78-84
[10]   Ciliary neurotrophic factor (CNTF) protects non-obese Swiss mice against type 2 diabetes by increasing beta cell mass and reducing insulin clearance [J].
Rezende, L. F. ;
Santos, G. J. ;
Santos-Silva, J. C. ;
Carneiro, E. M. ;
Boschero, A. C. .
DIABETOLOGIA, 2012, 55 (05) :1495-1504